Clopidogrel: A multifaceted affair
Author:
Affiliation:
1. Cardiology Department; Complejo Hospitalario Universitario Insular Materno Infantil; Las Palmas de Gran Canaria Spain
2. Research Unit; Complejo Hospitalario Universitario Insular Materno Infantil; Las Palmas de Gran Canaria Spain
Funder
Fundación Canaria de Investigación en Salud
Publisher
Wiley
Subject
Pharmacology (medical),Pharmacology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/jcph.413/fullpdf
Reference99 articles.
1. Antiplatelet therapies for the treatment of cardiovascular disease;Michelson;Nat Rev Drug Discov,2010
2. Clinical pharmacology of the adenosine diphosphate (ADP) receptor antagonist, clopidogrel;Schrör;Vasc Med,1998
3. Results of the CAPRIE trial: efficacy and safety of clopidogrel. Clopidogrel versus aspirin in patients at risk of ischaemic events;Creager;Vasc Med,1998
4. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation;Yusuf;N Engl J Med,2001
5. Benefit of clopidogrel in patients with acute coronary syndromes without ST-segment elevation in various risk groups;Budaj;Circulation,2002
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Variants in clopidogrel-relevant genes and early neurological deterioration in ischemic stroke patients receiving clopidogrel;BMC Neurology;2020-04-28
2. The correlation between recurrent risk and CYP2C19 gene polymorphisms in patients with ischemic stroke treated with clopidogrel for prevention;Medicine;2020-03
3. CYP2C19 or CYP3A5 Genotyping Does Not Predict Clinical Response to Clopidogrel;The Journal of Clinical Pharmacology;2018-05-03
4. The value of using polymorphisms in anti-platelet therapy;Frontiers in Biology;2017-10
5. Interaction of CYP2C19, P2Y12, and GPIIIa Variants Associates With Efficacy of Clopidogrel and Adverse Events on Patients With Ischemic Stroke;Clinical and Applied Thrombosis/Hemostasis;2016-05-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3